Publications

Found 9 results
Filters: Keyword is Macaca mulatta  [Clear All Filters]
2012
Moldt B, Rakasz EG, Schultz N, Chan-Hui P-Y, Swiderek K, Weisgrau KL, Piaskowski SM, Bergman Z, Watkins DI, Poignard P et al..  2012.  Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo.. Proc Natl Acad Sci U S A. 109(46):18921-5.
Barouch DH, Klasse P J, Dufour J, Veazey RS, Moore JP.  2012.  Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission.. Proc Natl Acad Sci U S A. 109(22):8694-8.
Moldt B, Shibata-Koyama M, Rakasz EG, Schultz N, Kanda Y, Dunlop CD, Finstad SL, Jin C, Landucci G, Alpert MD et al..  2012.  A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques.. J Virol. 86(11):6189-96.
Dyavar Shetty R, Velu V, Titanji K, Bosinger SE, Freeman GJ, Silvestri G, Amara R R.  2012.  PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques.. J Clin Invest. 122(5):1712-6.
Vanderford TH, Slichter C, Rogers KA, Lawson BO, Obaede R, Else JG, Villinger F, Bosinger SE, Silvestri G.  2012.  Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation.. Blood. 119(24):5750-7.
Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, Lynch DM, Iampietro JM, Sanmiguel A, Seaman MS, Ferrari G et al..  2012.  Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.. Nature. 482(7383):89-93.